Dentsply Sirona/$XRAY
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Dentsply Sirona
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
- Ticker
- $XRAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 14,000
- Headquarters
- Charlotte, United States
- Website
- www.dentsplysirona.com
Dentsply Sirona Metrics
BasicAdvanced
$1.7B
-
-$2.73
0.85
$0.32
7.38%
Price and volume
Market cap
$1.7B
Beta
0.85
52-week high
$14.76
52-week low
$8.59
Average daily volume
4.5M
Dividend rate
$0.32
Financial strength
Current ratio
1.627
Quick ratio
0.725
Long term debt to equity
1.551
Total debt to equity
1.722
Interest coverage (TTM)
1.70%
Profitability
EBITDA (TTM)
526
Gross margin (TTM)
49.52%
Net profit margin (TTM)
-14.99%
Operating margin (TTM)
4.86%
Effective tax rate (TTM)
-57.64%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
1.96%
Return on equity (TTM)
-33.03%
Valuation
Price to revenue (TTM)
0.475
Price to book
1.28
Price to tangible book (TTM)
-2.63
Price to free cash flow (TTM)
12.108
Free cash flow yield (TTM)
8.26%
Free cash flow per share (TTM)
0.716
Dividend yield (TTM)
3.69%
Forward dividend yield
7.38%
Growth
Revenue change (TTM)
-0.76%
Earnings per share change (TTM)
-42.61%
3-year revenue growth (CAGR)
-2.55%
10-year revenue growth (CAGR)
1.58%
3-year earnings per share growth (CAGR)
-17.08%
10-year earnings per share growth (CAGR)
2.53%
3-year dividend per share growth (CAGR)
-15.48%
10-year dividend per share growth (CAGR)
0.65%
What the Analysts think about Dentsply Sirona
Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.
Analyst projections of the future price of Dentsply Sirona stock.
Bulls say / Bears say
Dentsply Sirona returned to GAAP profitability in Q2, earning $37 million versus a $45 million loss a year earlier, while gross margin rose to 54.9% from 52.4%. This suggests some improvement in its financial footing, although adjusted EPS was flat. (GlobeNewswire)
Wellspect sales grew 7.1% in Q2 while three other segments declined, giving the business a growing unit to lean on as the turnaround proceeds. (RTTNews)
Dentsply Sirona launched an FDA-cleared, CE-approved AI diagnostic aid that works with existing compatible scanners through its DS Core platform. This could add value to its digital offering without requiring customers to replace their imaging equipment. (GlobeNewswire)
Q2 net sales fell 6.3% at constant currency, with Orthodontic and Implant Solutions down 13.2% and three of four segments contracting. Continued weakness in key businesses could make the recovery harder to deliver. (GlobeNewswire)
Underlying earnings remain under pressure: adjusted EBITDA fell 3.3% and adjusted EPS was flat, while the quarter's cash-flow improvement included about $44 million of tariff refunds. That makes the reported cash rebound less persuasive as evidence of recurring progress. (GlobeNewswire)
Net debt stood at 3.2 times EBITDA, and the company expected $60–65 million of charges under its 2026 restructuring plan, most to be paid in 2026 and 2027. High leverage and cash restructuring costs leave less room for execution missteps. (The Motley Fool, StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2026.
Dentsply Sirona Financial Performance
Revenues and expenses
Dentsply Sirona Earnings Performance
Company profitability
Upcoming events
No upcoming events
Dentsply Sirona News
AllArticlesVideos
Funds containing Dentsply Sirona
AllEURGBPUSD
Fund name | Fund size | $XRAY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.06% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.06% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.05% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.05% |
Amundi S&P 500£500G | £6.6B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.